Citation

Debika Bhattacharya, Camlin Tierney, Kevin Butler, Flavia Matovu Kiweewa, Dhayendre Moodley, Vani Govender, Tichaona Vhembo, Neaka Mohtashemi, Hannah Ship, Dingase Dula, Kathy George, Nahida Chaktoura, Karin L Klingman, Mary Glenn Fowler, Marion G Peters, Judith S. Currier. Comparison of Antiretroviral Therapies in Pregnant Women Living With Human Immunodeficiency Virus and Hepatitis B Virus: A Randomized Controlled Trial. Obstetrics and Gynecology. 2023 Aug 03; PMID: 37535953.

Citation

Kristina M. Brooks, Jennifer J. Kiser, Lauren Ziemba, Shawn Ward, Yasha Rani, Tim R. Cressey, Gaerolwe R. Masheto, Haseena Cassim, Jaime G. Deville, Ponego L. Ponatshego, Faeezah Patel, Linda Aurpibul, Shaun L. Barnabas, Iris Mustich, Anne Coletti, Barbara Heckman, Chelsea Krotje, Mark Lojacono, Dwight E. Yin, Ellen Townley, Jack Moye, Sai Majji, Edward P. Acosta, Kevin Ryan, Hardik Chandasana, Cynthia H. Brothers, Ann M. Buchanan, Helena Rabie, Patricia M. Flynn, IMPAACT 2019 Study Team. Pharmacokinetics, Safety, and Tolerability of Dispersible and Immediate-Release Abacavir, Dolutegravir and Lamivudine Tablets in Children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study. Lancet HIV. 2023 Aug 02; 10(8):E506-E517. PMID: 37541705.

Citation

Mutsa Bwakura-Dangarembizi, Lauren Ziemba, Camlin Tierney, Christina Reding, Frederic Bone, Sarah Bradford, Diane Costello, Renee Browning, John Moye, Tichaona Vhembo, James S. Ngocho, Macpherson Mallewa, Lameck Chinula, Philippa Musoke, Maxensia Owor, IMPAACT P1092 Team. Micronutrients and Nutritional Status among Children living with HIV with and without Severe Acute Malnutrition: IMPAACT P1092. BMC Nutrition. 2023 Nov 02; PMID: 37919816; PMCID: PMC10621230.

Citation

Amita Gupta, Priya Singh, Lisa Aaron, Grace Montepiedra, Tsungai Chipato, Lynda Stranix-Chibanda, Vongai Chanaiwa, Tichaona Vhembo, Mercy Mutambanengwe, Gaerolwe Masheto, Mpho Raesi, Sarah Bradford, Amanda Golner, Diane Costello, Vandana Kulkarni, Aisa Shayo, Enid Kabugho, Patrick Jean–Phillippe, Nahida Chakhtoura, Timothy R. Sterling, Gerhard Theron, Adriana Weinberg, IMPAACT P1078 TB APPRISE Study Team. Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial. Lancet Child and Adolescent Health. 2023 Oct 07; 7(10):708-717. PMID: 37634517; PMCID: PMC10883460.

Citation

Hardik Chandasana, Mita Thapar, Siobhan Hayes, Mark Baker, Diana M Gibb, Anna Turkova, Deborah Ford, Theodore Ruel, Andrew Wiznia, Lee Fairlie, Mutsawashe Bwakura-Dangarembizi, Hilda Mujuru, Carmelita Alvero, Mona Farhad, Rohan Hazra, Ellen Townley, Ann Buchanan, Pauline Bollen, Hylke Waalewijn, Angela Colbers, David Burger, Edward P. Acosta, Rajendra Singh, IMPAACT P1093 and ODYSSEY (PENTA 20) Study Teams. Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents. Clinical Pharmacokinetics. 2023 Aug 21; 62(10):1445-1459. PMID: 37603217; PMCID: PMC10520196.

Citation

Marije Van Schalkwyk, Adrie Bekker, Eric Decloedt, Jiajia Wang, Gerhard B. Theron, Mark F. Cotton, Ahizechukwu C. Eke, Tim R. Cressey, David E. Shapiro, Kira Bacon, Kevin Knowles, Kathleen George, Renee Browning, Nahida Chakhtoura, Kittipong Rungruengthanakit, Lubbe Wiesner, Edmund V. Capparelli, Alice M. Stek, Mark Mirochnick, Brookie M. Best, IMPAACT P1026s Protocol Team. Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s. Journal Antimicrobial Agents and Chemotherapy. 2023 Nov 15; 67(11):e0073723. PMID: 37882552; PMCID: PMC10648924.

Citation

Jeremiah D. Momper, Mina Nikanjam, Brookie M. Best, Mark Mirochnick, Edmund V. Capparelli, Tim R. Cressey. Dolutegravir Plasma Protein Binding and Unbound Concentrations During Pregnancy and Postpartum. Journal of Acquired Immune Deficiency Syndromes. 2023 Dec 01; 94(4):332-336. PMID: 37884053; PMCID: PMC10686188.

Citation

Linda Aurpibul, Ann Melvin, Supattra Rungmaitree, Brookie M. Best, Xiang Li, Meredith G. Warshaw, Hong Wan, Nicole H. Tobin, Patricia Jumes, Randi Leavitt, Katie McCarthy, Rachel Scheckter, Pradthana Ounchanum, Avy Violari, Hedy Teppler, Havilland Campbell, Chelsea Krotje, Ellen Townley, Jack Moye, IMPAACT 2014 study team. Efficacy, safety, and tolerability of doravirine/lamivudine/tenofovir disoproxil fumarate fixed-dose combination tablets in adolescents living with HIV: results through week 96 from IMPAACT 2014. Journal of the Pediatric Infectious Diseases Society. 2023 Dec 16; 12(12):602-609. PMID: 37815035; PMCID: PMC11494224.

Citation

Kristina M. Brooks, Mauricio Pinilla, Alice M. Stek, David E. Shapiro, Emily Barr, Irma L. Febo, Mary E. Paul, Jaime G. Deville, Kathleen George, Kevin Knowles, Kittipong Rungruengthanakit, Renee Browning, Nahida Chakhtoura, Edmund V. Capparelli, Mark Mirochnick, Brookie M. Best, IMPAACT P1026s Protocol Team. Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s. Journal of Acquired Immune Deficiency Syndromes. 2022 Jul 01; 90(3):343-350. PMID: 35195573; PMCID: PMC9203910.

Citation

Kristin Baltrusaitis, Bonus Makanani, Camlin Tierney, Mary Glenn Fowler, Dhayendre Moodley, Gerhard Theron, Lynette H Nyakudya, Musunga Tomu, Lee Fairlie, Kathleen George, Barbra Heckman, Kevin Knowles, Renee Browning, George K Siberry, Taha E Taha, Lynda Stranix-Chibanda, PROMISE P1084s Study Team. Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial. BMC Infectious Diseases. 2022 Jul 20; 22(1):634. PMID: 35858874; PMCID: PMC9297643.